Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Healthy Adults × adagrasib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Colorectal Neoplasms 5 Neoplasms 3 Neoplasm Metastasis 3 Colonic Neoplasms 3 Pancreatic Neoplasms 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Advanced Solid Tumor 2 Kidney Neoplasms 1 Healthy Adults 1

Interventions

eltrombopag 1 adagrasib 1 Peptides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05924152 2024-03-13

A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib

Mirati Therapeutics Inc.

Phase 1 Completed

Healthy Adults

Data powered by HemOnc (CC BY 4.0) Colophon ⚡